Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.

Persons

Aaron Seth Kesselheim

Venue / Journal

Drug Saf

Date

Mon, 03/01/2021 - 12:00

Additional Journal Information

44(3):327-335

Authors

Sarpatwari A, He M, Tessema FA, Gagne JJ, Kesselheim AS.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/33206339